4-HO-MET vs Psilocybin: Similar but Not the Same

4-HO-MET is a synthetic tryptamine closely related to the active compound in magic mushrooms. This guide compares what is known about each, why the evidence gap matters, interaction risks and legal status.

Wild brown mushrooms growing on moss, illustrating the comparison between psilocybin and synthetic tryptamines

Educational content. This article does not provide dosing, sourcing or buying information. It explains health risks so readers can make safer decisions and recognise when someone needs help.

Psilocybin is the best-known compound in “magic mushrooms” and is now being studied in clinical trials for depression and other conditions. 4-HO-MET (sometimes called metocin) is a synthetic tryptamine that is chemically very close to psilocin, the substance psilocybin turns into in the body. Because of this resemblance it is sometimes described as a “synthetic mushroom”. That label hides important differences in what is known about each substance and in how they reach people. Our wider guide to designer tryptamines and their health risks gives more background on this family.

What are 4-HO-MET and psilocybin?

Psilocybin occurs naturally in more than a hundred species of mushroom. After it is swallowed, the body converts it into psilocin, which produces the psychedelic effects. Clinical-grade psilocybin is made under strict pharmaceutical standards for research.

4-HO-MET is a laboratory-made tryptamine with no history of traditional or medical use. It was first described in the scientific literature in the late twentieth century and later appeared on the new psychoactive substances market, usually as powders or capsules of uncertain content.

How they affect the body

Both act mainly on serotonin 5-HT2A receptors in the brain, which is the shared mechanism behind classic psychedelic effects: changes in perception, mood and thinking, and visual distortions. Users often describe 4-HO-MET as more visual and less emotionally intense than mushrooms, but these accounts are anecdotal.

The key difference is the evidence base:

  • Psilocybin has been studied in controlled human trials, with screening, preparation and medical supervision, so its short-term effects and risks are relatively well described.
  • 4-HO-MET has essentially no formal human research. Its safety profile, how it is processed by the body and how it interacts with medicines are largely unknown.
Close relatives, different evidencePsilocybinin mushroomsPsilocinactive in body4-HO-METsynthetic analogueClinical trials, decades of dataAlmost no human researchSimilar structure does not mean similar safety knowledge.
4-HO-MET is structurally close to psilocin, but its safety has not been studied.

Reported side effects

Reported side effects for both substances include:

  • Nausea and stomach discomfort
  • Raised heart rate and blood pressure
  • Dilated pupils, yawning and muscle tension
  • Anxiety, panic and confusion
  • Distressing hallucinations or a frightening “bad trip”
  • Lingering visual disturbances in a small number of people

Main health risks compared

Unknown contents and strength

Mushrooms vary naturally in strength, but they are at least a known organism. 4-HO-MET is sold as a powder or capsule whose identity and purity cannot be checked without lab testing. Mislabelling is common across the new psychoactive substances market, as our article What Are “Research Chemicals”? explains.

Psychological risks

Any psychedelic can trigger intense fear, panic or confusion, and can lead to risky behaviour or accidents. People with a personal or family history of psychosis or bipolar disorder are at higher risk of lasting mental health problems. Clinical trials screen these people out; unsupervised use does not.

Lack of safety data

With psilocybin, researchers have a reasonable picture of what to expect. With 4-HO-MET there is no such picture, which makes unexpected reactions harder for medical staff to anticipate.

Dangerous combinations

These interactions are risks to be aware of, not guidance:

  • Lithium – combining lithium with psychedelics has been linked to seizures.
  • MAOIs (some antidepressants and ayahuasca-type preparations) – can greatly intensify and prolong tryptamine effects in unpredictable ways.
  • Stimulants and MDMA-type drugs – extra strain on the heart and a risk of serotonin-related toxicity.
  • Tramadol – raises seizure and serotonin syndrome risk.
  • Cannabis – may intensify anxiety and confusion.

Emergency warning signs

  • Seizures
  • Very high temperature, heavy sweating, muscle rigidity or twitching
  • Chest pain or a very fast, irregular heartbeat
  • Extreme agitation or behaviour that puts the person or others in danger
  • Loss of consciousness

What to do

Call 112 (EU), 999 (UK) or 911 (US) if any of these signs appear. If the person is unconscious but breathing, place them in the recovery position and stay with them. For someone who is frightened but physically well, a calm, quiet, safe space and a reassuring person nearby can help; if distress does not ease or you are unsure, seek medical help. Tell paramedics what you know was taken.

Legal status

This is a general overview, not legal advice.

  • Netherlands: Psilocybin and psilocin are controlled under the Opium Act, and fresh and dried magic mushrooms have been banned since 2008. Synthetic tryptamines are increasingly targeted by Dutch and EU controls on new psychoactive substances.
  • Germany: Psilocybin and psilocin are controlled under narcotics law, and many synthetic tryptamines are covered by the New Psychoactive Substances Act (NpSG).
  • UK: Psilocybin and magic mushrooms are Class A. Many ring-substituted tryptamines, including 4-HO-MET, fall under Class A generic controls; otherwise supply is still an offence under the Psychoactive Substances Act 2016.
  • US: Psilocybin and psilocin are federally Schedule I. A few states have created regulated or decriminalised frameworks. 4-HO-MET may be treated as an analogue of psilocin under federal law.

For how analogues are treated in the US, see our guide to the US Federal Analogue Act.

Getting help

  • Netherlands: Drugs Infolijn (Trimbos); DIMS drug-checking can test what is really in a sample.
  • UK: FRANK, 0300 123 6600.
  • US: SAMHSA National Helpline, 1-800-662-4357.

Related reading

Frequently asked questions

Is 4-HO-MET the same as magic mushrooms?

No. It is chemically related to psilocin, but it is a separate synthetic substance with almost no research behind it.

Does psilocybin research make 4-HO-MET safe?

No. Clinical findings apply to pharmaceutical-grade psilocybin given with screening and supervision. They cannot be transferred to a different, untested compound.

Why is mixing with lithium dangerous?

Reports link lithium combined with psychedelics to seizures. Anyone taking prescribed psychiatric medication should speak to their doctor about interaction risks.

This article is for general information and is not medical advice. If you are worried about your own or someone else’s drug use, speak to a doctor or one of the services listed above.

Share on Twitter
✦ Written by
Research Chemicals Blog Editorial Team

The Research Chemicals Blog editorial team writes independent guides on laboratory chemicals, reagents and suppliers, and evidence-based drug-safety information drawn from public-health sources such as the EU Drugs Agency, WHO, NHS and NIDA. We never sell, recommend or link to sellers of psychoactive substances, and we never publish dosing or sourcing information.

ResearchChemicals.blog

© 2026 researchchemicals.blog · Independent guides for laboratory buyers. Not affiliated with any supplier named on this site.